A researcher at Russia’s anti-plague institute in Irkutsk, eastern Siberia, has died from a suspected case of pneumonic plague, a severe bacterial lung infection. Following the death, local authorities placed nearly 190 people under medical observation due to potential exposure. While the World Health Organization (WHO) confirmed awareness of the reports and offered assistance, laboratory tests are still underway to verify the cause of death. The WHO emphasized that all identified contacts are being monitored, and currently, no symptoms have been reported among them.

Plague, caused by the bacterium Yersinia pestis, is rare but remains endemic in several regions worldwide, including parts of the western United States. The disease is typically associated with bubonic plague, characterized by swollen lymph nodes, but pneumonic plague, which infects the lungs, can spread through respiratory droplets and poses a greater risk for contagion. Although treatable with antibiotics, resistant strains of the bacterium are a growing concern. The situation involving a lab worker may suggest potential exposure to such resistant strains, but details remain unclear.

Russian health authorities, including Rospotrebnadzor, have described the situation in Irkutsk and the nearby city of Shelekhov as stable, with control measures in place. The deceased worker was initially reported to have "pneumonia of unknown etiology." Conflicting reports about the worker’s recent travels have emerged, with local officials disputing some claims. There has been no confirmation regarding whether the lab staffer was handling particularly dangerous strains, and no relevant microorganisms linked to the case have been detected so far.

Experts highlight that although plague cases number around 2,000 annually worldwide and are generally manageable with antibiotics, emerging resistance could complicate treatment. The possibility that the lab worker was involved in vaccine research or handling weaponizable strains has also been suggested. The WHO currently assesses the public health risk from this case as low but continues to monitor developments closely. Meanwhile, global attention remains focused on further confirmation and containment of the suspected infection in Siberia.